baber/WOPTO huggingface dataset:
Patent JP-2693307-B2 (JP)
IPC: G06N5/04
Filed: 1991-09-30
Granted: 1997-12-24
Abstract: PURPOSE:To effectively perform the self-recovery to a failure by use of a case in which recovering work is described. CONSTITUTION:Cases are hierarchically classified according to failure symptoms, failures and classes, and a case suitable to a caused failure is selected to perform recovering work. In the application of the case, the case is corrected at need. When the work ends in a success by the corrected case, the corrected case is registered to the same class as the original case to complete the cases. Application priorities are given to the classes, and when the applicable case is present in plural classes, the application priorities are referred to at need. When the application of the case is successful, the application priority of the class to which the case belongs is raised to make this class easy to apply. The application priority of the related class is also raised to properly cope with a failure occurring from the same cause. When the failure can not be recovered by the case application, the work is inferred by qualitative inference to recover the failure. When it is successful, the inferred work is registered as the case of a new class.
Patent JP-H0780826-B2 (JP)
IPC: C07D295/28
Filed: 1988-10-27
Abstract: The invention relates to a process for the synthesis of N,N-dialkyl-hydroxylamines by reaction of the corresponding dialkylamine with H2O2, said reaction being carried out in the presence of a catalyst based on titanium-silicalite.
Patent JP-2740775-B2 (JP)
IPC: A61K38/13
Filed: 1991-11-01
Granted: 1998-04-15
Abstract: It has been found that nonimmunosuppressive, cyclophilin-binding cyclosporins are useful in the treatment and prevention of AIDS and AIDS-related disorders. Such cyclosporins include novel Ciclosporin derivatives modified at the 4- and/or 5-positions.
Patent JP-H0438884-B2 (JP)
IPC: F01M1/06
Filed: 1986-12-27
Abstract: PURPOSE:To control the lubricating oil quantity simply and at a low cost by providing switching pins for connecting and disconnecting plural cam followers, which are adapted to control the lubricating oil quantity in oil paths disposed in the cam followers with the movement between the connecting position and the disconnecting positions. CONSTITUTION:During high-speed operation of an engine, high oil pressure is supplied to an oil pressure chamber 29 so that switching pins 23-25 are moved against a return spring 26 and the first and second switching pins 23, 24 engage with the second and third guide holes 33, 34 to connect rocker arms 7-9 to one another. At this time, the first and third switching pins 23, 25 are moved to throttle between, oil paths 42, 43 and between oil paths 47, 48, so that only a small quantity of lubricating oil is supplied to a sliding contact surface between a low speed cam and a cam slipper. On the other hand, oil paths 50, 51 are communicated with each other through a circular groove 49 by the movement of the second switching pin 24, so that lubricating oil from an oil pressure supply path 31 is supplied to a sliding contact surface between a high-speed cam and a cam slipper.
Patent JP-2988163-B2 (JP)
IPC: G05D9/00
Filed: 1992-10-30
Granted: 1999-12-06
Abstract: A water level regulating system controlling the water level of a head tank of each of a plurality of hydroelectric plant installed in cascade along a stream by using an opening of guide vanes (201, 203) of a hydraulic turbine (202, 204) as a manipulated variable, and the water level of the head tank as a controlled variable. Each hydroelectric plant has a water level regulator (100A, 100B) constituting the water level regulating system. Each of the water level regulator (100A) of an upstream hydroelectric plant and the water level regulator (100B) of a downstream hydroelectric plant has a device (103, 106) varying PID parameters for controlling the water level in accordance with the opening ( phi 1,  phi 2) of the guide vanes (201, 203), and a device (101, 104) varying a reference water level (Sv1', Sv2') to a set water level (Sv1, Sv2). The downstream water level regulator (100B) further includes a feedforward compensating element (107) which compensates a feedforward signal corresponding to the opening ( phi 1) of the guide vanes (201) of the upstream hydroelectric plant, and which varies its compensation characteristic by the opening ( phi 2) of the guide vanes of the downstream hydroelectric plant. This arrangement makes it possible to quickly stabilize the water level of the head tank which may vary owing to changes in the operating state of the turbines or in an intake volume. <IMAGE>
Patent JP-2529544-B2 (JP)
IPC: A61K31/435
Filed: 1994-12-21
Granted: 1996-08-28
Abstract: 7β-Acylamino-3-trifluoromethylsulfonyloxy-1-carba-3-cephem-4-carboxylic acid antibitic compounds, esters and salts thereof, and the corresponding 7-amino and protected 7-amino 1-carbacephalosporins are provided. The 3-trifluoromethylsulfonyloxy-substituted 1-carbacephalosporins also are useful in a process for preparing 3-halo-1-carbacephalosporins which comprises displacing the 3-trifluoromethylsulfonyloxy ester group with halide ion in an aprotic polar solvent.
Patent JP-3461520-B2 (JP)
IPC: G06F11/22
Filed: 1992-11-30
Granted: 2003-10-27
Abstract: A multiprocessor system comprising a networking apparatus (2) and a plurality of data processing apparatuses (11 to 1n) for transferring data through the networking apparatus (2) from one to another of the plurality of data processing apparatuses. The networking apparatus (2) contains: a switch unit (3) for switching data transfer paths between data processing apparatuses; a priority control unit (4) for determining and controlling the data transfer paths in response to requests from the data processing apparatuses; and an abnormality detecting unit (5) for monitoring the operation of the priority control unit (4), generating and outputing to the data processing apparatus which has output the requests an abnormality informing signal. When the networking apparatus is comprised of a plurality of stages each containing at least one switch circuit for switching data transfer paths, an abnormality detection circuit and an abnormality detection signal transferring unit are provided for each switch circuit, for transferring the abnormality detection signal along the route for the data transfer passing through the switch circuit, in a direction opposite to the direction of the data transfer. Further, identification of the stage at which the abnormality detection signal has been generated, may be maintained until the abnormality detection signal reaches the data processing apparatus. <IMAGE>
Patent JP-2755745-B2 (JP)
IPC: E03C1/04
Filed: 1989-12-08
Granted: 1998-05-25
Abstract: Security device for assembling both parts of a tap body, characterised in that the two parts (1 and 2) fit together axially and are assembled with the aid of radial screws (5) normally hidden under a ring (6) which is free in terms of rotation but immobilised axially, the said ring having a hole (9) for access to the abovementioned screws. In the case of a mixing tap, in which the rotation of the glass plate (11), performing the mixing, is controlled by a push-piece (15), the push-piece is fixed to the ring (6) and closes the hole (9) of the latter. <IMAGE>
Patent JP-3236291-B2 (JP)
IPC: A61K31/435
Filed: 1991-11-05
Granted: 2001-12-10
Abstract: A new compound 3-Methoxysampangine and its analogs, compositions thereof, and method of using as an antifungal agent particularly effective against Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
Patent JP-3222887-B2 (JP)
IPC: C08L95/00
Filed: 1991-12-17
Granted: 2001-10-29
Abstract: PCT No. PCT/FR91/01018 Sec. 371 Date Oct. 6, 1992 Sec. 102(e) Date Oct. 6, 1992 PCT Filed Dec. 17, 1991 PCT Pub. No. WO92/11321 PCT Pub. Date Jul. 9, 1992.A bitumen/polymer component of the type consisting of a hydrocarbon matrix is provided in which a sulphur-crosslinked elastomer is distributed homogeneously in a quantity such that it presents 5% to 20% by weight of the bitumen/polymer component. The component exhibits a penetration, determined according to NF standard T 66004, and a ball-and-ring softening temperature, determined according to NF standard T 66008, such that the Pfeiffer number, which links these quantities, assumes values greater than 5 in the case of the bitumen/polymer component.
Patent JP-3459250-B2 (JP)
IPC: D01D5/253
Filed: 1992-07-23
Granted: 2003-10-20
Abstract: A napkin comprises an absorbent core between a pervious topsheet and an impervious backsheet, with all parts extensible, and a fastener for securing the napkin to the garment, the fastener allowing at least parts of the napkin to extend. The napkin is pref. extensible both longitudinally and transversely and may require extending before applying to the garment, or may be extended by forces applied during use. Stretched length is pref. at least 25% greater than unstretched length. The napkin may be provided with a pull-out tab so that the user can lengthen the napkin.
Patent JP-3494377-B2 (JP)
IPC: A61F2/958
Filed: 1991-01-08
Granted: 2004-02-09
Abstract: An elongated catheter having an interior and an exterior surface, wherein the interior surface defines a lumen passing through the catheter. The catheter further including an enclosed cavity between the interior and exterior surfaces which encircles of the lumen. The cavity having an inner wall and an outer wall, the outer wall being a resilient sleeve which can stretch generally independently of the inner wall. The cavity containing an amount of a suitable lubricating substance effective to permit the resilient sleeve to slide along an outer surface of the inner wall while in lubricated contact therewith when stretched independently of the inner wall, wherein the inner wall and the outer wall are joined together at distal end proximal ends of the enclosed cavity. An automated method for producing the same, including a series of automated dipping steps, is also disclosed. A Foley catheter having a balloon portion and a lubricated resilient sleeve, as disclosed above, is also disclosed, as are methods for manufacturing the same.
Patent JP-3668950-B2 (JP)
IPC: A61K38/08
Filed: 1995-06-27
Granted: 2005-07-06
Abstract: The invention is a peptide of general formula (I) X-Tyr-Y-Phe-Z-A, wherein: X represents H or Arg, D-Arg, Orn, D-Orn, Lys, D-Lys, Har, D-Har, Cyt, D-Cyt; Y represents D-Ala, D-Val, D-Leu, D-Ile, D-Phe, D-Asn, D-Trp, D-Pro, D-Ser, D-Thr, D-Tyr, D-Hyp, D-Cys, D-Cys-Cys, D-Met, D-Lys, D-Har, D-Arg, D-His, D-Asp, D-Glu, D- beta -Ala, D-Orn; Z represents Ala, D-Ala, Val, D-Val, Leu, D-Leu, Ile, D-Ile, Phe, D-Phe, Asn, D-Asn, Gly, Gln, D-Gln, Trp, D-Trp, Pro, D-Pro, Ser, D-Ser, Thr, D-Thr, Tyr, D-Tyr, Hyp, D-Hyp, Cys, D-Cys, Cys-Cys, Cys-D-Cys, D-Cys-Cys, D-Cys-D-Cys, Met, D-Met, Lys, D-Lys, Arg, D-Arg, His, D-His, Asp, D-Asp, Glu, D-Glu,  beta -Ala, D- beta -Ala, Orn, D-Orn; and A represents OH or a substituted amide (C1-C3). According to the invention, the proposed peptide of general formula (I) is obtained by the gradual construction of a peptide chain, starting from C-terminated amino acide Z, in the form of a substituted amide or carboxyl-protected group, by addition using the method of activated ethers or mixed anhydrides of a successive N-protected amino acid; the N-protective group is split off and the successive N-protected amino acid is re-added to produce a tetra- or pentapeptide which is unblocked in the presence of a palladium catalyst, and the target product is separated out. The proposed peptide and a compound based on it can be used as an agent with pronounced opiate-like properties and also has anabolic properties which increase body weight as well as promoting activity in the growing zones and development of the epidermal layer including the hair. The bio-stimulating properties of the claimed peptide are also evident in the healing of wounds and repair processes.
Patent JP-3828926-B2 (JP)
IPC: C07J7/00
Filed: 1994-07-28
Granted: 2006-10-04
Abstract: PCT No. PCT/EP94/02513 Sec. 371 Date Jan. 18, 1996 Sec. 102(e) Date Jan. 18, 1996 PCT Filed Jul. 28, 1994 PCT Pub. No. WO95/04536 PCT Pub. Date Feb. 16, 1995The invention relates to the use of antiglucocorticoid steroids for the manufacture of a pharmaceutical composition for the treatment of anxiety disorders.
Patent JP-2892155-B2 (JP)
IPC: F23C99/00
Filed: 1989-09-20
Granted: 1999-05-17
Abstract: This invention relates to the reduction of oxidized sulfur compound SOX emissions produced during combustion of sulfur (S)-containing combustible compounds. More particularly, this invention provides a method for reducing such emissions wherein the combustible compound is mixed with an admixture of a water soluble and a water insoluble sulfur sorbent. Use of such admixtures, remarkably, produces a reduction in the SOX level far greater than would be expected based on the activity of each sorbent alone. Extremely viscous hydrocarbons can be burned as preatomized fuels, which can also be mixed with sorbent admixtures. Clean burning fuels comprising sulfur-containing combustible compounds and sorbent admixtures are also provided.
Patent JP-3278676-B2 (JP)
IPC: A61K31/715
Filed: 1992-04-14
Granted: 2002-04-30
Abstract: The invention relates to new heparin derivatives from bovine or porcine heparin which have a molecular weight equal to or larger than the standard heparin, show a sulfur content which is equal to or higher than that of the starting heparin or at least 13% w/w, have an anticoagulant activity in the anti-FXa assay of less than 10% of the standard heparin it was made from, show a ratio of APTT activity over anti-FXa activity of 3-35, show a reduced prolongation of bleeding time compared to the standard heparin it was made from as measured in the rat tail after i.v. administration and show enhancement of the rate of development of coronary collaterals in dogs equal to or better than clinically used heparin. The invention also relates to processes for preparation of the new bovine and porcine heparin derivatives. The use of this product for the manufacturing of a medicament for treatment of ischemic heart disease and related vascular disorders and for the enhancement of the rate of development of coronary collateral perfusion is disclosed.
Patent JP-2610605-B2 (JP)
IPC: F16J15/3296
Filed: 1991-05-23
Granted: 1997-05-14
Abstract: A configuration for sealing off a duct gap between a housing wall and a shaft includes a sealing ring surrounding the shaft to be set into rotation relative to the housing wall. The sealing ring is sealed off with respect to the housing wall and the shaft. The sealing ring is displaceable relative to the housing wall and is incapable of being set into rotation by the shaft. At least one spring element is to be placed under a mechanical strain by a torque exerted upon the sealing ring by the rotation of the shaft. The strain is determined and a report is issued, if the strain deviates substantially from a predeterminable normal value.
Patent JP-3003873-B2 (JP)
IPC: G02B6/00
Filed: 1992-04-28
Granted: 2000-01-31
Abstract: The calibration device (16) includes an optical-delay recirculation loop (22) constituted by two delaying fibres (F2, F3), an optical amplifier (28) and a coupler (26) for supplying a succession of several delayed optical signals (OR) in response to a single initial optical signal (OA). This invention applies especially to radars. <IMAGE>
Patent JP-3464796-B2 (JP)
IPC: C12N15/12
Filed: 1992-04-06
Granted: 2003-11-10
Abstract: An antagonist or agonist compound for use in the treatment of hypercalcemia or hypocalcemia. The compound is identifiable as being a compound capable of competing with a parathyroid hormone or parathyroid hormone-related protein for binding to a parathyroid hormone receptor. Identification is carried out by contacting a polypeptide with a parathyroid hormone or parathyroid hormone-related protein in the presence or absence of a candidate compound. The polypeptide comprises at least six amino acids and less than the complete amino acid sequence of a parathyroid hormone receptor having an amino acid sequence with at least 30% identity to the amino acid sequence shown in SEQ. ID NO. 3.
Patent JP-3311355-B2 (JP)
IPC: A43C11/16
Filed: 1993-11-02
Granted: 2002-08-05
Abstract: A shoe of the type having a sole and an upper formed of nonrigid materials attached to the sole, and with a central closure mechanism that is coupled with at least one elongated flexible tightening element by which a vamp of the upper can be tightened and loosened via increasing and decreasing an effective length of the at least one tightening element as measured from the central closure mechanism as it runs between guide elements on the upper and on an instep shield. In accordance with preferred embodiments, the shoe upper has a closed vamp, at least the instep area of which is formed of a volume-elastic compressible material and the instep cover is formed of an elastically bendable material at least approximately matched to the surface contour at least a portion of the instep. Additionally, the central closure is provided on the outside of the back of the upper above the heel, and the tightening element runs from the central closure along both sides of the shoe, via a guide element provided curving around the heel from near the height of the insole, without crossing the instep, to a higher guide element provided on the instep cover and then to a forward guide element lying at the level of the insole on the outside of the shoe upper near the small toe at the medial side of the shoe and in the area between the metatarsophalangeal joint of the big toe and approximately the center of the arch on the lateral side of the shoe.
Patent JP-3381920-B2 (JP)
IPC: A61B17/56
Filed: 1993-01-18
Granted: 2003-03-04
Abstract: PCT No. PCT/FI93/00015 Sec. 371 Date Oct. 14, 1994 Sec. 102(e) Date Oct. 14, 1994 PCT Filed Jan. 18, 1993 PCT Pub. No. WO93/14706 PCT Pub. Date Aug. 5, 1993A surgical instrument for installing an implant in a living tissue. The instrument includes a frame including an installation channel that is adapted for receiving the implant and is adapted to be placed in connection with the tissue. The implant is inserted in the tissue when it exits the installation channel. The frame includes an installation end. Apparatus produces a reciprocating movement that is transmitted to the implant to produce a periodic movement in the implant. An installation member conveys an external installation force to the implant for installing the implant. The installation member is insertable in the installation channel.
Patent JP-4276703-B2 (JP)
IPC: A61P43/00
Filed: 1998-09-07
Granted: 2009-06-10
Abstract: The present invention relates to novel compounds, to a method for the preparation of these novel compounds, to pharmaceutical compositions containing one or more of these compounds as an active component and to methods of using these in the treatment of stress-related disorders.
Patent JP-4435305-B2 (JP)
IPC: C07K16/44
Filed: 1996-11-27
Granted: 2010-03-17
Abstract: The present invention provides a topiramate immunoassay and reagents for use in the immunoassay. In particular, topiramate is derivatized at the sulfamate moiety or the 9-carbon or 10-carbon methyl group of topiramate to add a label bound directly or through a linking group for use as a tracer (competitive analyte analog) or to add a linking group bound to a carrier for use as an immunogen to induce anti-topiramate antibodies. Immunoassay methods and kits are also provided.
Patent JP-4311762-B2 (JP)
IPC: H01M8/04014
Filed: 1996-11-21
Granted: 2009-08-12
Abstract: The invention concerns a method of operating a high-temperature fuel cell system (2) comprising a high-temperature fuel cell module (4) with an anode part (20) and a cathode part (22). The fuel gas necessary for the electrochemical reaction is generated by a gas reforming process, more hydrogen (H2) being generated than is consumed during the electrochemical reaction in the high-temperature fuel cell module (4). The hydrogen (H2) not consumed in the high-temperature fuel cell module (4) is made available for further use outside the high-temperature fuel cell module (4). Owing to this measure, the efficiency of the high-temperature fuel cell system (2) is optimized.
Patent JP-3875722-B2 (JP)
IPC: C12N9/78
Filed: 1996-12-12
Granted: 2007-01-31
Abstract: A solution having a high concentration of ammonium (meth)acrylate and which is substantially free of (meth)acrylonitrile is made by enzymatic hydrolysis of (meth)acrylonitrile in the presence of water using an enzyme that has Km for (meth)acrylonitrile below 500 mum and Ki for ammonium (meth)acrylate about 100,000.
Patent JP-3318715-B2 (JP)
IPC: A61B17/12
Filed: 1997-11-17
Granted: 2002-08-26
Abstract: The present invention relates to a puncture seal for sealing a blood vessel having a puncture opening in a body of a human being or an animal. Said seal comprises a pressure chamber (23) which can be attached to the body in the area of the puncture opening and subjected to an overpressure, wherein the pressure chamber (23) has a supporting wall (21) in an area opposite to the body. In order to create a puncture seal, in which the pressure chamber (23) can be reliably sealed once the hypodermic needle has been removed, a sealing element (25) made of a material with a certain elastic return force, which is at least 1 mm thick is provided and placed in the area of the supporting wall (21) to be punctured by the hypodermic needle.
Patent JP-3662021-B2 (JP)
IPC: C07K14/705
Filed: 1994-05-12
Granted: 2005-06-22
Abstract: The present invention provides compositions comprising at least one complement moiety and at least one carbohydrate moiety, and methods of producing such compositions. In particular, the compositions of the invention comprise complement proteins related to the complement receptor type 1, and further comprise ligands for intercellular molecules, such as selectins. In a preferred embodiment, the compositions comprise a complement-related protein in combination with the Lewis X antigen or the sialyl Lewis X antigen. The compositions of the invention have use in the diagnosis or therapy of disorders involving complement activity and inflammation. Pharmaceutical compositions are also provided for treating or reducing inflammation mediated by inappropriate complement activity and intercellular adhesion.
Patent JP-3275024-B2 (JP)
IPC: A61K38/00
Filed: 1996-03-01
Granted: 2002-04-15
Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
Patent JP-3830162-B2 (JP)
IPC: A61B5/0295
Filed: 1996-03-15
Granted: 2006-10-04
Abstract: A method is disclosed for determining the aortic flow velocity waveform non-invasively. A calibrated ascending aorta pressure waveform can be derived from peripheral measurements, for example at the radial artery, and calibrated from conventional syphgmomanometry, for example at the brachial artery. From the calibrated ascending aorta pressure waveform the flow velocity waveform in the ascending aorta can be determined, by using the Fourier transform of the pressure waveform and the age-related phase and modulus values. The method can also be used for invasively measured pressure waveforms to provide a flow waveform.